Προκλήσεις για τις φαρμακευτικές εταιρείες και τρόποι αντιμετώπισης
KeywordsΦαρμακευτική αγορά ; Φαρμακευτικός κλάδος ; Φαρμακευτική βιομηχανία ; Φαρμακευτικές δαπάνες ; Καινοτομία ; Εξορθολογισμός δαπανών υγείας ; Έρευνα απόψεων ; Rebates & clawbacks
This Master Thesis was developed within the postgraduate program "Economics and Health Management" of the Department of Economics of the University of Piraeus. The aim of the thesis is the research and analysis of the pharmaceutical industry and the challenges that Greek pharmaceutical companies are facing today along with their prospects, not only in the context of the economic crisis but also in a constantly changing environment. The Pharmaceutical Industry is one of the few sectors in Greece that has a healthy track, albeit with slow growth. It seems to resist to the ongoing changes of the external environment and manage with flexibility all efforts of additional regulations from the Authorities. In this endeavor, the industry is currently at a crucial turning point, handling the effects of the Fiscal Crisis, on a system that a drastic reduction in health spending, is considered the only way out. In the second part of the paper, the field research was investigated using a questionnaire, addressed both to pharmaceutical executives and to Health Care Professionals. This research has been carried out in two phases, so it is divided into preliminary research and final research. The results are analyzed separately, but overall, considering that in this way delivering better and more effectively the answers of respondents.